Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106895212 | 10689521 | 2 | F | 201412 | 20160817 | 20150105 | 20160825 | PER | US-AMGEN INC.-USASP2014102502 | AMGEN | 68.00 | YR | E | F | Y | 0.00000 | 20160824 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106895212 | 10689521 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 1052264 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 106895212 | 10689521 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | 1063617 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 106895212 | 10689521 | 3 | C | ASPIRIN. | ASPIRIN | 1 | UNK UNK, QD | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106895212 | 10689521 | 1 | Psoriatic arthropathy |
| 106895212 | 10689521 | 2 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106895212 | 10689521 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106895212 | 10689521 | Feeling abnormal | |
| 106895212 | 10689521 | Fibromyalgia | |
| 106895212 | 10689521 | Injection site erythema | |
| 106895212 | 10689521 | Injection site haemorrhage | |
| 106895212 | 10689521 | Injection site hypertrophy | |
| 106895212 | 10689521 | Injection site inflammation | |
| 106895212 | 10689521 | Injection site mass | |
| 106895212 | 10689521 | Injection site pain | |
| 106895212 | 10689521 | Injection site rash | |
| 106895212 | 10689521 | Injection site reaction | |
| 106895212 | 10689521 | Injection site swelling | |
| 106895212 | 10689521 | Injection site warmth | |
| 106895212 | 10689521 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106895212 | 10689521 | 1 | 20141210 | 0 |